Occupe actuellement un poste chez Bloom Energy Corp
Position | Company | Period |
---|---|---|
Independent Director | Bloom Energy Corp | 1 janvier 2003 - |
Lead Independent Director | Tableau Software LLC | None - |
Independent Director | Workday Inc | 1 juillet 2009 - 3 juin 2014 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-04-24 | 2024-04-22 |
Frequency Therapeutics Inc
(FREQ)
|
A Achat |
17 857
+1.7%
56,00999 992 USD |
17 857 +1.7% | 56,00 | 999 992 USD | |
2023-11-22 | 2023-11-20 |
Cloudflare Inc
(NET)
|
VP Vente planifiée |
78 389
-69.4%
73,025 723 965 USD |
78 389 -69.4% | 73,02 | 5 723 965 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
V Vente |
6 570
-100.0%
66,57437 335 USD |
6 570 -100.0% | 66,57 | 437 335 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
V Vente |
2 944
-30.9%
65,30192 254 USD |
2 944 -30.9% | 65,30 | 192 254 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
V Vente |
9 455
-49.8%
64,54610 194 USD |
9 455 -49.8% | 64,54 | 610 194 USD | |
2023-08-09 | 2023-08-08 |
Cloudflare Inc
(NET)
|
V Vente |
1 338
-6.6%
63,8185 374 USD |
1 338 -6.6% | 63,81 | 85 374 USD | |
2023-07-19 | 2023-07-17 |
Savara Inc
(SVRA)
|
A Achat |
333 333
+1.4%
3,00999 999 USD |
333 333 +1.4% | 3,00 | 999 999 USD | |
2023-01-27 | 2023-01-26 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
1 351 092
-37.7%
3,124 213 786 USD |
1 351 092 -37.7% | 3,12 | 4 213 786 USD | |
2023-01-27 | 2023-01-26 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
1 648 908
-37.7%
3,125 142 614 USD |
1 648 908 -37.7% | 3,12 | 5 142 614 USD | |
2023-01-27 | 2023-01-25 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
293 645
-7.6%
3,26958 428 USD |
293 645 -7.6% | 3,26 | 958 428 USD | |
2023-01-27 | 2023-01-25 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
358 371
-7.6%
3,261 169 687 USD |
358 371 -7.6% | 3,26 | 1 169 687 USD | |
2023-01-06 | 2023-01-05 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
32 139
-0.8%
2,7688 659 USD |
32 139 -0.8% | 2,76 | 88 659 USD | |
2023-01-06 | 2023-01-05 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
39 223
-0.8%
2,76108 201 USD |
39 223 -0.8% | 2,76 | 108 201 USD | |
2023-01-04 | 2023-01-04 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
45 930
-1.2%
2,91133 643 USD |
45 930 -1.2% | 2,91 | 133 643 USD | |
2023-01-04 | 2023-01-04 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
56 054
-1.2%
2,91163 100 USD |
56 054 -1.2% | 2,91 | 163 100 USD | |
2023-01-04 | 2023-01-03 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
78 730
-1.9%
2,99235 411 USD |
78 730 -1.9% | 2,99 | 235 411 USD | |
2023-01-04 | 2023-01-03 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
96 084
-1.9%
2,99287 301 USD |
96 084 -1.9% | 2,99 | 287 301 USD | |
2023-01-04 | 2022-12-30 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
54 645
-1.3%
3,02165 028 USD |
54 645 -1.3% | 3,02 | 165 028 USD | |
2023-01-04 | 2022-12-30 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
66 690
-1.3%
3,02201 404 USD |
66 690 -1.3% | 3,02 | 201 404 USD | |
2022-12-27 | 2022-12-23 |
Arcellx Inc
(ACLX)
|
V Vente |
195
-100.0%
31,676 176 USD |
195 -100.0% | 31,67 | 6 176 USD | |
2022-12-27 | 2022-12-23 |
Arcellx Inc
(ACLX)
|
V Vente |
195
-100.0%
31,676 176 USD |
195 -100.0% | 31,67 | 6 176 USD | |
2022-12-22 | 2022-12-21 |
Arcellx Inc
(ACLX)
|
V Vente |
179
-100.0%
30,745 502 USD |
179 -100.0% | 30,74 | 5 502 USD | |
2022-05-26 | 2022-05-25 |
Genocea Biosciences Inc
(GNCA)
|
V Vente |
4 445 093
-100.0%
0,08362 720 USD |
4 445 093 -100.0% | 0,08 | 362 720 USD | |
2022-05-26 | 2022-05-24 |
Genocea Biosciences Inc
(GNCA)
|
V Vente |
5 931 843
-57.2%
0,07387 943 USD |
5 931 843 -57.2% | 0,07 | 387 943 USD | |
2022-05-16 | 2022-05-12 |
Robinhood Markets Inc
(HOOD)
|
V Vente |
4 396
-100.0%
8,4136 970 USD |
4 396 -100.0% | 8,41 | 36 970 USD | |
2022-05-16 | 2022-05-12 |
Robinhood Markets Inc
(HOOD)
|
V Vente |
4 396
-100.0%
8,4136 970 USD |
4 396 -100.0% | 8,41 | 36 970 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
948 948
+inf%
1,901 803 001 USD |
948 948 +inf% | 1,90 | 1 803 001 USD | |
2022-04-13 | 2022-04-11 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
2 631 578
+33.8%
1,904 999 998 USD |
2 631 578 +33.8% | 1,90 | 4 999 998 USD | |
2021-10-19 | 2021-10-18 |
Trevi Therapeutics Inc
(TRVI)
|
A Achat |
1 851 852
0,000 USD |
1 851 852 | 0,00 | 0 USD | |
2021-03-18 | 2021-03-16 |
Marker Therapeutics Inc
(MRKR)
|
A Achat |
5 714 285
+114.3%
1,759 999 999 USD |
5 714 285 +114.3% | 1,75 | 9 999 999 USD | |
2020-06-22 | 2020-06-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
1 428 571
+56.6%
5,257 499 998 USD |
1 428 571 +56.6% | 5,25 | 7 499 998 USD | |
2019-04-08 | 2019-04-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
4 347 827
+20.8%
1,144 956 523 USD |
4 347 827 +20.8% | 1,14 | 4 956 523 USD | |
2018-12-21 | 2018-12-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
300 000
+1.5%
1,49448 380 USD |
300 000 +1.5% | 1,49 | 448 380 USD | |
2018-12-21 | 2018-12-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
200 000
+1.0%
1,63326 060 USD |
200 000 +1.0% | 1,63 | 326 060 USD | |
2018-12-12 | 2018-12-11 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
61 200
+0.3%
1,98121 084 USD |
61 200 +0.3% | 1,98 | 121 084 USD | |
2018-12-10 | 2018-12-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
26 000
+0.1%
1,9851 576 USD |
26 000 +0.1% | 1,98 | 51 576 USD | |
2018-12-10 | 2018-12-07 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
117 100
+0.6%
1,98232 362 USD |
117 100 +0.6% | 1,98 | 232 362 USD | |
2018-12-10 | 2018-12-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
27 300
+0.1%
1,9954 414 USD |
27 300 +0.1% | 1,99 | 54 414 USD | |
2018-11-30 | 2018-11-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
71 900
+0.4%
1,98142 067 USD |
71 900 +0.4% | 1,98 | 142 067 USD | |
2018-11-30 | 2018-11-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
24 500
+0.1%
1,9948 824 USD |
24 500 +0.1% | 1,99 | 48 824 USD | |
2018-11-21 | 2018-11-20 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
170 000
+0.9%
1,98336 107 USD |
170 000 +0.9% | 1,98 | 336 107 USD | |
2018-11-19 | 2018-11-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
510 000
+2.6%
1,88956 658 USD |
510 000 +2.6% | 1,88 | 956 658 USD | |
2018-11-19 | 2018-11-16 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
350 000
+1.8%
1,86649 355 USD |
350 000 +1.8% | 1,86 | 649 355 USD | |
2018-11-19 | 2018-11-15 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
340 000
+1.8%
1,86631 958 USD |
340 000 +1.8% | 1,86 | 631 958 USD | |
2018-08-22 | 2018-08-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
663 716
+3.7%
2,261 499 998 USD |
663 716 +3.7% | 2,26 | 1 499 998 USD | |
2018-07-20 | 2018-07-19 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
50 600
+0.3%
2,00101 165 USD |
50 600 +0.3% | 2,00 | 101 165 USD | |
2018-07-20 | 2018-07-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
200 000
+1.1%
1,95390 580 USD |
200 000 +1.1% | 1,95 | 390 580 USD | |
2018-06-28 | 2018-06-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
187 130
+1.1%
2,10392 692 USD |
187 130 +1.1% | 2,10 | 392 692 USD | |
2018-06-28 | 2018-06-27 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
5 295
+0.0%
2,1511 384 USD |
5 295 +0.0% | 2,15 | 11 384 USD | |
2018-05-30 | 2018-05-30 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
275
+0.0%
2,15591 USD |
275 +0.0% | 2,15 | 591 USD | |
2018-05-21 | 2018-05-21 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
32 200
+0.2%
2,1469 059 USD |
32 200 +0.2% | 2,14 | 69 059 USD | |
2018-05-21 | 2018-05-18 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
20 100
+0.1%
2,1442 928 USD |
20 100 +0.1% | 2,14 | 42 928 USD | |
2018-05-21 | 2018-05-17 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
184 179
+1.1%
2,13391 436 USD |
184 179 +1.1% | 2,13 | 391 436 USD | |
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
5 533
-0.1%
17,8198 543 USD |
5 533 -0.1% | 17,81 | 98 543 USD | |
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
4 006
-0.1%
17,8171 347 USD |
4 006 -0.1% | 17,81 | 71 347 USD | |
2018-05-10 | 2018-05-08 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
70 873
+0.4%
2,13151 250 USD |
70 873 +0.4% | 2,13 | 151 250 USD | |
2018-04-10 | 2018-04-10 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
203 200
+1.2%
2,46499 994 USD |
203 200 +1.2% | 2,46 | 499 994 USD | |
2018-04-10 | 2018-04-09 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
32 100
+0.2%
2,4378 099 USD |
32 100 +0.2% | 2,43 | 78 099 USD | |
2018-04-10 | 2018-04-06 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
685 676
+4.2%
2,241 536 943 USD |
685 676 +4.2% | 2,24 | 1 536 943 USD | |
2017-03-29 | 2017-03-28 |
Aveo Pharmaceuticals Inc
(AVEO)
|
A Achat |
6 000 000
+57.9%
0,503 000 000 USD |
6 000 000 +57.9% | 0,50 | 3 000 000 USD | |
2015-11-18 | 2015-11-16 |
GlycoMimetics Inc
(GLYC)
|
V Vente |
452
-0.0%
6,913 123 USD |
452 -0.0% | 6,91 | 3 123 USD | |
2014-08-29 | 2014-08-29 |
Sunesis Pharmaceuticals Inc
(SNSS)
|
V Vente |
11 600
-0.2%
7,5187 070 USD |
11 600 -0.2% | 7,51 | 87 070 USD | |
2014-08-12 | 2014-08-12 |
Sunesis Pharmaceuticals Inc
(SNSS)
|
V Vente |
35 540
-0.7%
6,76240 190 USD |
35 540 -0.7% | 6,76 | 240 190 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
A Achat |
512 500
+14.3%
8,004 100 000 USD |
512 500 +14.3% | 8,00 | 4 100 000 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
A Achat |
487 500
+12.2%
8,003 900 000 USD |
487 500 +12.2% | 8,00 | 3 900 000 USD | |
2004-10-01 | 2004-09-29 |
Gilead Colorado Inc
(MYOG)
|
A Achat |
858 235
+25.7%
6,505 578 528 USD |
858 235 +25.7% | 6,50 | 5 578 528 USD |